DK162811C - Oploesninger af maelkesure salte af piperazinyl-quinolon- og piperazinyl-azaquinolon-carboxylsyrer, deres fremstilling og antibakterielt laegemiddel indeholdende disse oploesninger - Google Patents

Oploesninger af maelkesure salte af piperazinyl-quinolon- og piperazinyl-azaquinolon-carboxylsyrer, deres fremstilling og antibakterielt laegemiddel indeholdende disse oploesninger

Info

Publication number
DK162811C
DK162811C DK441084A DK441084A DK162811C DK 162811 C DK162811 C DK 162811C DK 441084 A DK441084 A DK 441084A DK 441084 A DK441084 A DK 441084A DK 162811 C DK162811 C DK 162811C
Authority
DK
Denmark
Prior art keywords
piperazinyl
solutions
azaquinolon
quinolon
preparation
Prior art date
Application number
DK441084A
Other languages
Danish (da)
English (en)
Other versions
DK441084A (da
DK162811B (da
DK441084D0 (da
Inventor
Klaus Grohe
Robert Lammens
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6209428&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK162811(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK441084D0 publication Critical patent/DK441084D0/da
Publication of DK441084A publication Critical patent/DK441084A/da
Publication of DK162811B publication Critical patent/DK162811B/da
Application granted granted Critical
Publication of DK162811C publication Critical patent/DK162811C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
DK441084A 1983-09-17 1984-09-14 Oploesninger af maelkesure salte af piperazinyl-quinolon- og piperazinyl-azaquinolon-carboxylsyrer, deres fremstilling og antibakterielt laegemiddel indeholdende disse oploesninger DK162811C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3333719 1983-09-17
DE19833333719 DE3333719A1 (de) 1983-09-17 1983-09-17 Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren

Publications (4)

Publication Number Publication Date
DK441084D0 DK441084D0 (da) 1984-09-14
DK441084A DK441084A (da) 1985-03-18
DK162811B DK162811B (da) 1991-12-16
DK162811C true DK162811C (da) 1992-05-04

Family

ID=6209428

Family Applications (1)

Application Number Title Priority Date Filing Date
DK441084A DK162811C (da) 1983-09-17 1984-09-14 Oploesninger af maelkesure salte af piperazinyl-quinolon- og piperazinyl-azaquinolon-carboxylsyrer, deres fremstilling og antibakterielt laegemiddel indeholdende disse oploesninger

Country Status (24)

Country Link
US (3) US4705789A (fr)
EP (1) EP0138018B1 (fr)
JP (1) JPS6094910A (fr)
KR (1) KR870001958B1 (fr)
AU (1) AU562507B2 (fr)
CA (1) CA1228547A (fr)
DD (1) DD227882A5 (fr)
DE (2) DE3333719A1 (fr)
DK (1) DK162811C (fr)
ES (1) ES8607021A1 (fr)
FI (1) FI83286C (fr)
GR (1) GR80364B (fr)
HK (1) HK74789A (fr)
HU (1) HU194733B (fr)
IE (1) IE57905B1 (fr)
IL (1) IL72953A (fr)
NO (1) NO171765C (fr)
NZ (1) NZ209548A (fr)
PL (1) PL144897B1 (fr)
PT (1) PT79206B (fr)
SG (1) SG21489G (fr)
SU (1) SU1384187A3 (fr)
UA (1) UA8025A1 (fr)
ZA (1) ZA847267B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3608745A1 (de) * 1985-07-24 1987-01-29 Bayer Ag Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
IL80459A (en) * 1986-10-30 1991-04-15 Abic Ltd Water-soluble adduct of norfloxacin and nicotinic acid
JPH0696533B2 (ja) * 1987-01-14 1994-11-30 北陸製薬株式会社 キノロンカルボン酸の水性組成物
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
US5225413A (en) * 1988-09-16 1993-07-06 Bayer-Aktiengesellschaft pH-neutral aqueous solutions of quinolone-carboxylic acids
NZ232091A (en) * 1989-01-16 1990-12-21 Bellon Labor Sa Roger 7-fluoro-8-(piperazin-1-yl)-4-oxo-1,4-dihydro-benzo(b)(1,8)naphthyridine-3-carboxylic acid derivatives, preparation and pharmaceutical compositions thereof
DK0507851T3 (da) * 1989-12-29 1997-08-25 Abbott Lab Quinoloncarboxylsyre-matalion-syrekomplekser
KR0159540B1 (ko) * 1992-01-21 1998-12-01 김정순 퀴놀론-카복실산의 염 및 그 함유조성물
TW254855B (fr) * 1993-07-28 1995-08-21 Otsuka Pharma Co Ltd
ES2127036B1 (es) * 1994-03-21 1999-11-16 Ind Quimica Agropecuaria S A Aducto de norfloxacina soluble en agua.
KR960000223A (ko) * 1994-06-08 1996-01-25 김정순 신규한 피리돈 카르복실산 화합물을 함유한 수용액 및 이의 제조방법
ES2088742B1 (es) * 1994-06-29 1997-03-16 Salvat Lab Sa Composicion antibiotica de aplicacion otica.
JPH08213881A (ja) * 1995-02-02 1996-08-20 Fujitsu Ltd 周波数制御回路
DE19730023A1 (de) * 1997-07-11 1999-01-14 Bayer Ag Hochreine Ciprofloxacin-Infusion
IN186245B (fr) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
DE69922339T2 (de) 1998-09-18 2006-01-05 Senju Pharmaceutical Co., Ltd. Methode zur lösung von pyridoncarboxylsäuren und wässrige lösungen die pyridoncarboxylsäuren enthalten
DE102004005186B3 (de) * 2004-02-02 2005-10-13 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von gereinigtem Ciprofloxacin
DE102004054873A1 (de) 2004-11-12 2006-05-18 Bayer Healthcare Ag Behandlung von Mastitis
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
NZ555641A (en) * 2004-12-09 2010-10-29 Bayer Animal Health Gmbh Stabilisation of glucocorticoid esters with acids
SG176056A1 (en) 2009-05-15 2011-12-29 Redx Pharma Ltd Redox drug derivatives
CN103479569A (zh) * 2013-01-14 2014-01-01 四川喜亚动物药业有限公司 兽用环丙沙星注射液及其制备方法
WO2016094588A2 (fr) 2014-12-09 2016-06-16 Heflin John A Système d'alignement de colonne vertébrale

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE296839C (fr) *
CH296839A (de) * 1944-03-14 1954-02-28 Knoll Ag Verfahren zur Herstellung von haltbaren, wässrigen Lösungen von Salzen von Strychninoxyd.
DE2047486A1 (de) * 1970-09-26 1972-03-30 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur Stabilisierung einer pynthioxinhaltigen, wässerigen Injektions lösung
US4022894A (en) * 1975-03-03 1977-05-10 Fainberg Samuel M Stable solution of benzthiazide (3-[benzythiol methyl]-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide) suitable for parenteral administration and process of preparation
JPS6019910B2 (ja) * 1979-10-11 1985-05-18 大塚製薬株式会社 ベンゾ〔ij〕キノリジン−2−カルボン酸誘導体及びその製造法
JPS5531028A (en) * 1978-08-25 1980-03-05 Dai Ichi Seiyaku Co Ltd Injection
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
DE2918319A1 (de) * 1979-05-07 1980-11-13 Roehm Pharma Gmbh Therapeutische verabreichungsform
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
JPS57188515A (en) * 1981-05-13 1982-11-19 Kyoto Yakuhin Kogyo Kk Stabilized aqueous dopamine preparation
ES512969A0 (es) * 1981-06-11 1983-02-16 Warner Lambert Co "un procedimiento para preparar sales de compuestos de naftiridina y quinoleina".

Also Published As

Publication number Publication date
DD227882A5 (de) 1985-10-02
IE57905B1 (en) 1993-05-05
ES535832A0 (es) 1986-05-16
PL249591A1 (en) 1987-03-09
ES8607021A1 (es) 1986-05-16
US4808583A (en) 1989-02-28
DK441084A (da) 1985-03-18
NO843518L (no) 1985-03-18
FI83286B (fi) 1991-03-15
KR870001958B1 (ko) 1987-10-23
DE3474915D1 (en) 1988-12-08
IE842347L (en) 1985-03-17
EP0138018A3 (en) 1986-10-08
EP0138018B1 (fr) 1988-11-02
HU194733B (en) 1988-03-28
NO171765B (no) 1993-01-25
US4705789A (en) 1987-11-10
US4808585A (en) 1989-02-28
HK74789A (en) 1989-09-22
SG21489G (en) 1989-09-22
SU1384187A3 (ru) 1988-03-23
PT79206A (en) 1984-10-01
KR850002096A (ko) 1985-05-06
JPH0559893B2 (fr) 1993-09-01
FI83286C (fi) 1991-06-25
IL72953A (en) 1988-01-31
HUT35513A (en) 1985-07-29
UA8025A1 (uk) 1995-12-26
DE3333719A1 (de) 1985-04-04
IL72953A0 (en) 1984-12-31
JPS6094910A (ja) 1985-05-28
AU562507B2 (en) 1987-06-11
PT79206B (en) 1986-08-14
AU3297684A (en) 1985-03-21
GR80364B (en) 1985-01-14
ZA847267B (en) 1985-05-29
EP0138018A2 (fr) 1985-04-24
PL144897B1 (en) 1988-07-30
DK162811B (da) 1991-12-16
FI843587A0 (fi) 1984-09-13
NO171765C (no) 1993-05-05
CA1228547A (fr) 1987-10-27
DK441084D0 (da) 1984-09-14
NZ209548A (en) 1987-02-20
FI843587L (fi) 1985-03-18

Similar Documents

Publication Publication Date Title
DK162811C (da) Oploesninger af maelkesure salte af piperazinyl-quinolon- og piperazinyl-azaquinolon-carboxylsyrer, deres fremstilling og antibakterielt laegemiddel indeholdende disse oploesninger
DK58184A (da) 3-amino-1-benzazepin-2-on-1-alkansyrer og salte deraf samt deres fremstilling og anvendelse
DK474684A (da) 1-benzylaminoalkylpyrrolidinoner, syreadditionssalte deraf, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse
DK285685A (da) Farmaceutisk aktive derivater af d,l-glutaminsyre og d,l-asparaginsyre og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK600183D0 (da) Krystalliserede cephem-syreadditionssalte,deres fremstilling og anvendelse
DK358784A (da) Phenylquinolincarboxylsyrer, derivater og salte deraf, deres fremstilling og anvendelse i antitumormidler
DK256085A (da) Cephemforbindelser og salte og estere deraf, samt deres fremstilling og anvendelse
DK162053C (da) Temperaturstabile krystallinske salte af 7-oealfa-(2-amino-thiazol-4-yl)-alfa-(z)-methoxyiminoacetamidoaa-3-oe(1-ethyl-1-pyrrolidinium)-methylaa-3-cephem-4-carboxylat, fysiske blandinger af saltene og fremgangsmaade til fremstilling af svovlsyreadditionssaltet
DK23386A (da) Pyridopyrimidiner, deres fremstilling og anvendelse som laegemidler
DK95788D0 (da) Krystalliserede cephem-syreadditionssalte, deres fremstilling og anvendelse
DK383784A (da) Pyridazinylcarboxylsyrederivater samt deres fremstilling og anvendelse
DE3873167D1 (de) Thiazolidin-4-on-derivate und deren saeure-additionssalze.
DK165755C (da) Smoereoliepraeparat omfattende smoereolie, polyesterderivater og basiske salte af naftensyrer
DK222384D0 (da) 2-aminolavalkyl-2-penem-forbindelser og salte deraf samt deres fremstilling og anvendelse
DK355587D0 (da) 2-penem-3-carboxylsyre-forbindelser og salte deraf samt deres fremstilling og anvendelse
DK299983D0 (da) Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse
DK351284A (da) Substituerede thiazolidinylestere af mineralsyreamider og salte deraf samt deres fremstilling og anvendelse
DK325687D0 (da) Hydrogenerede 1-phenoxyalkylpyridin-3-carboxylsyreforbindelser og salte deraf samt deres fremstilling og anvendelse
DK300583D0 (da) Racemiske eller optisk aktive eburnanoximderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
NO164099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 2-klornicergolin og syreaddisjonssalter derav.
DK559486A (da) Substituerede benzoylurinstoffer og salte deraf samt deres fremstilling og anvendelse
DK247484D0 (da) Optisk aktive propionsyre-derivater,deres fremstilling og anvendelse
DK300383A (da) Racemiske eller optisk aktive e-homo-eburanderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
DK554688D0 (da) Farmaceutisk aktive derivater af (r)-5-pentyl-amino-5-oxopentansyre og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DK151783D0 (da) Racemiske eller optisk aktive berbanderivater eller salte deraf, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
PUP Patent expired